Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Morena Monti"'
Autor:
Emilo Franzoni, Morena Monti, Alessandro Pellicciari, Carlo Muratore, Alberto Verrotti, et al
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2009, Iss default, Pp 207-214 (2009)
Emilo Franzoni1, Morena Monti1, Alessandro Pellicciari1, Carlo Muratore1, Alberto Verrotti3, et al1Child Neuropsychiatry Unit, Clinical Pediatrics; 2Protection and Enhancement Department, University of Bologna, Italy; 3Clinic of Paediatrics, Universi
Externí odkaz:
https://doaj.org/article/9633e31a01d94804b7b38cf0981b8e42
Autor:
Elena Di Pietro, Alessandro Pellicciari, Morena Monti, Paola Gualandi, Luisa Iero, Leonardo Sacrato, Emilio Franzoni, Stefano Gualandi
Publikováno v:
European Eating Disorders Review. 20:e108-e113
Objective This study evaluates the psychometric properties of self-administered psychiatric scale for children and adolescents with psychogenic eating disorders (SAFA P)—a brief self-report designed to screen and assess eating disorders (ED) in chi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51f6ad31d1551ab82c1b25f4fafeff8f
https://doi.org/10.1002/erv.1099
https://doi.org/10.1002/erv.1099
Autor:
Emilio Franzoni, F. Chiarelli, Caterina Garone, Morena Monti, G. G. Salerno, Sara Matricardi, Alberto Verrotti, J. Sarajlija
Publikováno v:
European Journal of Neurology. 14:1334-1337
The present controlled study aims to evaluate topiramate (TPM) effect on total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein, very low-density lipoprotein, apolipoproteins A1, B and lipoprotein (a). Seventy patients in evo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dfbeaa265b06da15d570b947e455158
https://doi.org/10.1111/j.1468-1331.2007.01973.x
https://doi.org/10.1111/j.1468-1331.2007.01973.x
Autor:
Antonia Parmeggiani, G. G. Salerno, Morena Monti, Maria Cristina Scaduto, Margherita Santucci, Annio Posar
Publikováno v:
Journal of Pediatric Neurosciences
Introduction: Levetiracetam (LEV) is an effective antiepileptic drug also used in childhood and adolescence. Literature data regarding the long-term effects of LEV in childhood epilepsy and based on extensive neuropsychological evaluations using stan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f30e1a9457c5449b191d19095dce7b2
https://doi.org/10.4103/1817-1745.139282
https://doi.org/10.4103/1817-1745.139282
Autor:
I. Cecconi, Morena Monti, Emilio Franzoni, Bruno De Bernardi, Alberto Verrotti, Grazia Gabriella Salerno
Publikováno v:
European Journal of Paediatric Neurology. 11:36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::035e89d4fa7b045b7c3081939201e9cd
https://doi.org/10.1016/s1090-3798(08)70378-7
https://doi.org/10.1016/s1090-3798(08)70378-7
Autor:
GARONE, CATERINA, SALERNO, GRAZIA GABRIELLA, MONTI, MORENA, FRANZONI, EMILIO, Valentina Marchiani
La malattia di Pelizaeus-Merzbacher (PMD, OMIM 312080) è classificata tra le leucodistrofie ipomielinizzanti a trasmissione genetica ben definita [1], X-linked dovuta a mutazione del gene della proteina proteolipidica (PLP in Xq22) [2]. E’ clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4094::aa37d5582bcb691068804f2ecaec915c
http://hdl.handle.net/11585/53125
http://hdl.handle.net/11585/53125
